Artificial Exosome Composition for Targeted Cargo Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of conventional exosomes is a tedious, low-yield process with unclear mechanisms of delivery and unestablished essential components, hindering their clinical applications.
Innovation Solution
Development of artificial exosomes optimized for therapeutic and non-therapeutic use, comprising rab7, desmoplakin, alpha 2-HS glycoprotein, and cardiolipin, which are derived from a liposome base composition and can be loaded with cargo molecules for targeted delivery to cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional exosomes are produced from cells, then they can deliver cargo to target cells, but the production process is tedious and yields are low
Solution Approach 1:
The patent creates artificial exosomes by copying the essential structural and functional components of natural exosomes (lipid bilayer, specific proteins like rab7 and desmoplakin, and cardiolipin) without requiring complex cellular production systems. This allows high-yield production through chemical assembly rather than biological cultivation.
Solution Approach 2:
The patent uses liposomes as intermediary structures to build artificial exosomes. The liposome base composition provides a pre-formed lipid bilayer framework that can be subsequently modified with exosome-specific components, simplifying the overall production process while maintaining exosome functionality.
2Reliability
If natural exosomes are used for therapy, then they can transfer cargo to recipient cells, but the essential components and mechanisms are not well established
Solution Approach 1:
The patent segments the exosome system into discrete, identifiable components: a lipid bilayer base, specific structural proteins (rab7, desmoplakin, AHSG), and cardiolipin. This segmentation allows each component's function to be independently studied and optimized, establishing clear structure-function relationships.
Solution Approach 2:
The patent systematically varies parameters such as lipid composition ratios, protein concentrations, and cargo types to establish optimal conditions for delivery. This parametric approach enables the identification of essential components and their functional thresholds.
3Productivity
If artificial exosomes are designed with specific components, then delivery efficiency is enhanced, but the device complexity increases
Solution Approach 1:
The patent designs artificial exosomes with universal components that can accommodate various cargo types (nucleic acids, proteins, small molecules) through a standardized platform. The core structure remains consistent while allowing flexible cargo loading, reducing complexity compared to designing unique systems for each cargo type.
Data Source
AI summary
Novel artificial exosomes and methods for producing novel artificial exosomes are provided. Methods of delivering cargo molecules to a cell using artificial exosomes are also provided.